SEC Form 4 · accession 0001283841-16-000004
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth V Hetherington
Officer — Chief Medical Officer
Period of report
Nov 9, 2016
Accepted (ET)
Nov 9, 2016 · 5:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 9, 2016 | M | 5,000 | $2.02 | A | 26,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.02 | Nov 9, 2016 | M | 5,000 | D | — | Feb 17, 2021 | Common Stock | 5,000 | 61,955 | D |
Explanation of responses
- F1The option was granted on 2/17/2011 and the vesting schedule was completed in February 2015.